Literature DB >> 8440384

5-lipoxygenase-activating protein is an arachidonate binding protein.

J A Mancini1, M Abramovitz, M E Cox, E Wong, S Charleson, H Perrier, Z Wang, P Prasit, P J Vickers.   

Abstract

5-Lipoxygenase-activating protein (FLAP) is an 18-kDa integral membrane protein which is essential for cellular leukotriene (LT) synthesis, and is the target of LT biosynthesis inhibitors. However, the mechanism by which FLAP activates 5-LO has not been determined. We have expressed high levels of human FLAP in Spodoptera frugiperda (Sf9) insect cells infected with recombinant baculovirus, and used this system to demonstrate that FLAP specifically binds [125I]L-739,059, a novel photoaffinity analog of arachidonic acid. This binding is inhibited by both arachidonic acid and MK-886, an LT biosynthesis inhibitor which specifically interacts with FLAP. These studies suggest that FLAP may activate 5-LO by specifically binding arachidonic acid and transferring this substrate to the enzyme.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8440384     DOI: 10.1016/0014-5793(93)80528-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  40 in total

Review 1.  The enzymology and pharmacology of 5-lipoxygenase and 5-lipoxygenase activating protein.

Authors:  R L Bell; R R Harris
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

Review 2.  The organization and consequences of eicosanoid signaling.

Authors:  Roy J Soberman; Peter Christmas
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

3.  The membrane organization of leukotriene synthesis.

Authors:  Asim K Mandal; Jesse Skoch; Brian J Bacskai; Bradley T Hyman; Peter Christmas; Douglas Miller; Ting-ting D Yamin; Shihua Xu; Douglas Wisniewski; Jilly F Evans; Roy J Soberman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-14       Impact factor: 11.205

4.  Expression, purification and crystallization of human 5-lipoxygenase-activating protein with leukotriene-biosynthesis inhibitors.

Authors:  Shihua Xu; Brian M McKeever; Douglas Wisniewski; Douglas K Miller; Robert H Spencer; Lin Chu; Feroze Ujjainwalla; Ting Ting Yamin; Jilly F Evans; Joseph W Becker; Andrew D Ferguson
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-11-30

Review 5.  Significance of brain tissue oxygenation and the arachidonic acid cascade in stroke.

Authors:  Cameron Rink; Savita Khanna
Journal:  Antioxid Redox Signal       Date:  2010-12-04       Impact factor: 8.401

6.  Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma.

Authors:  A S Cowburn; K Sladek; J Soja; L Adamek; E Nizankowska; A Szczeklik; B K Lam; J F Penrose; F K Austen; S T Holgate; A P Sampson
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

7.  Common structural features of MAPEG -- a widespread superfamily of membrane associated proteins with highly divergent functions in eicosanoid and glutathione metabolism.

Authors:  P J Jakobsson; R Morgenstern; J Mancini; A Ford-Hutchinson; B Persson
Journal:  Protein Sci       Date:  1999-03       Impact factor: 6.725

8.  The nuclear membrane organization of leukotriene synthesis.

Authors:  Asim K Mandal; Phillip B Jones; Angela M Bair; Peter Christmas; Douglas Miller; Ting-ting D Yamin; Douglas Wisniewski; John Menke; Jilly F Evans; Bradley T Hyman; Brian Bacskai; Mei Chen; David M Lee; Boris Nikolic; Roy J Soberman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

9.  Myrtucommulone, a natural acylphloroglucinol, inhibits microsomal prostaglandin E(2) synthase-1.

Authors:  A Koeberle; F Pollastro; H Northoff; O Werz
Journal:  Br J Pharmacol       Date:  2009-03       Impact factor: 8.739

Review 10.  Regulation of leukotriene biosynthesis.

Authors:  A W Ford-Hutchinson
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.